Basel Medical Stock Forecast - Simple Moving Average

BMGL Stock   0.49  0.03  5.77%   
The Simple Moving Average forecasted value of Basel Medical Group on the next trading day is expected to be 0.49 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.31. Basel Stock Forecast is based on your current time horizon. Although Basel Medical's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Basel Medical's systematic risk associated with finding meaningful patterns of Basel Medical fundamentals over time.
As of now the relative strength index (rsi) of Basel Medical's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Basel Medical's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Basel Medical and does not consider all of the tangible or intangible factors available from Basel Medical's fundamental data. We analyze noise-free headlines and recent hype associated with Basel Medical Group, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Basel Medical's stock price prediction:
Quarterly Revenue Growth
0.322
Using Basel Medical hype-based prediction, you can estimate the value of Basel Medical Group from the perspective of Basel Medical response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Basel Medical Group on the next trading day is expected to be 0.49 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.31.

Basel Medical after-hype prediction price

    
  USD 0.49  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Basel Medical to cross-verify your projections.
At this time, Basel Medical's Payables Turnover is quite stable compared to the past year. Receivables Turnover is expected to rise to 4.29 this year, although the value of Inventory Turnover will most likely fall to 7.33. . The value of Common Stock Shares Outstanding is expected to slide to about 20.6 M.

Basel Medical Additional Predictive Modules

Most predictive techniques to examine Basel price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Basel using various technical indicators. When you analyze Basel charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A two period moving average forecast for Basel Medical is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Basel Medical Simple Moving Average Price Forecast For the 3rd of January

Given 90 days horizon, the Simple Moving Average forecasted value of Basel Medical Group on the next trading day is expected to be 0.49 with a mean absolute deviation of 0.06, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.31.
Please note that although there have been many attempts to predict Basel Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Basel Medical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Basel Medical Stock Forecast Pattern

Backtest Basel MedicalBasel Medical Price PredictionBuy or Sell Advice 

Basel Medical Forecasted Value

In the context of forecasting Basel Medical's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Basel Medical's downside and upside margins for the forecasting period are 0 and 6.77, respectively. We have considered Basel Medical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.49
0.49
Expected Value
6.77
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Basel Medical stock data series using in forecasting. Note that when a statistical model is used to represent Basel Medical stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria109.2396
BiasArithmetic mean of the errors 0.0276
MADMean absolute deviation0.0561
MAPEMean absolute percentage error0.0562
SAESum of the absolute errors3.31
The simple moving average model is conceptually a linear regression of the current value of Basel Medical Group price series against current and previous (unobserved) value of Basel Medical. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Basel Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Basel Medical Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.020.496.72
Details
Intrinsic
Valuation
LowRealHigh
0.020.476.70
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Basel Medical. Your research has to be compared to or analyzed against Basel Medical's peers to derive any actionable benefits. When done correctly, Basel Medical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Basel Medical Group.

Other Forecasting Options for Basel Medical

For every potential investor in Basel, whether a beginner or expert, Basel Medical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Basel Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Basel. Basic forecasting techniques help filter out the noise by identifying Basel Medical's price trends.

Basel Medical Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Basel Medical stock to make a market-neutral strategy. Peer analysis of Basel Medical could also be used in its relative valuation, which is a method of valuing Basel Medical by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Basel Medical Group Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Basel Medical's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Basel Medical's current price.

Basel Medical Market Strength Events

Market strength indicators help investors to evaluate how Basel Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Basel Medical shares will generate the highest return on investment. By undertsting and applying Basel Medical stock market strength indicators, traders can identify Basel Medical Group entry and exit signals to maximize returns.

Basel Medical Risk Indicators

The analysis of Basel Medical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Basel Medical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting basel stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Basel Medical Group is a strong investment it is important to analyze Basel Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Basel Medical's future performance. For an informed investment choice regarding Basel Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Basel Medical to cross-verify your projections.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Basel Medical. If investors know Basel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Basel Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.50)
Revenue Per Share
0.644
Quarterly Revenue Growth
0.322
Return On Assets
(0.05)
Return On Equity
(1.95)
The market value of Basel Medical Group is measured differently than its book value, which is the value of Basel that is recorded on the company's balance sheet. Investors also form their own opinion of Basel Medical's value that differs from its market value or its book value, called intrinsic value, which is Basel Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Basel Medical's market value can be influenced by many factors that don't directly affect Basel Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Basel Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Basel Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Basel Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.